Price:
Rs. 18,020.00
Sample Type: Chorionic Villi EDTA Blood
Fasting Not Required
Notes: D0028_C
Frequently Asked Questions (FAQ's):
What does the DMD/BMD 79 Exons Deletion/Duplication test include?
This test identifies exon-level deletions or duplications in the dystrophin gene (XP21), which are the most common mutations causing DMD and BMD.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated molecular techniques like MLPA or NGS-based copy number analysis to detect deletions and duplications accurately.
Who should take this test?
Patients with clinical signs of Duchenne or Becker Muscular Dystrophy, family members for carrier detection, or individuals undergoing prenatal or preconception evaluation may be advised to take this test.
What sample type is required?
An EDTA anticoagulated blood sample is required to extract high-quality DNA for reliable deletion/duplication analysis.
Why is detecting deletions and duplications important?
Exon-level deletions or duplications are the primary causes of DMD/BMD; identifying them helps confirm diagnosis, guide prognosis, and support therapeutic and genetic counseling decisions.
How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows strict quality control, validated molecular protocols, and expert interpretation to ensure accurate and reproducible results.
Is any preparation needed before the test?
No special preparation or fasting is required; patients should follow physician instructions for sample collection.
How soon are results available?
Turnaround time may vary depending on test complexity, but Metropolis Healthcare provides detailed and timely reports to support clinical and genetic decision-making.